Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

ClinicalTrials.gov ID: NCT06388564

Public ClinicalTrials.gov record NCT06388564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Study identification

NCT ID
NCT06388564
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Incyte Corporation
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • Axatilimab Drug
  • Corticosteroids Drug
  • Ruxolitinib Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2024
Primary completion
May 31, 2027
Completion
Nov 30, 2029
Last update posted
Mar 22, 2026

2024 – 2029

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Mayo Clinic Hospital Phoenix Arizona 85054 Recruiting
City of Hope Medical Center Duarte California 91010 Recruiting
University of California-Los Angeles Medl Cntr-Oncology Center Bowyer Clinic Los Angeles California 90095 Recruiting
Stanford Cancer Center Stanford California 94305 Recruiting
University of Colorado Cancer Center Aurora Colorado 80045 Recruiting
Colorado Blood Cancer Institute Denver Colorado 80218 Recruiting
Smilow Cancer Center-Yale New Haven Connecticut 06510 Recruiting
Mayo Clinic Jacksonville Jacksonville Florida 32224 Recruiting
Northwestern University Chicago Illinois 60611 Recruiting
The University of Chicago Medicine Chicago Illinois 60637 Recruiting
University of Maryland-Greenebaum Cancer Center Baltimore Maryland 21201 Recruiting
Massachusetts General Hospital Boston Massachusetts 02144 Withdrawn
Washington University St Louis Missouri 63110 Recruiting
Fred and Pamela Buffett Cancer Center Omaha Nebraska 68198 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10021 Recruiting
Weill Cornell Medicine New York New York 10021 Recruiting
Mount Sinai Hospital New York New York 10029 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
The Ohio State University Columbus Ohio 43210 Recruiting
University of Pennsylvania Abramson Cancer Center Philadelphia Pennsylvania 19104 Recruiting
Hillman Cancer Center Pittsburgh Pennsylvania 15232 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37232 Recruiting
Md Anderson Cancer Center Houston Texas 77030 Recruiting
Fred Hutchinson Cancer Center Seattle Washington 98109 Recruiting
University of Washington Seattle Washington 98195 Recruiting
Froedtert & the Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06388564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06388564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →